Loading...
•
Jun 30, 2023
Health Catalyst Q2 2023 Earnings Report
Reported financial results, with revenue and Adjusted EBITDA beating the mid-point of quarterly guidance. Full year revenue and Adjusted EBITDA guidance were raised.
Key Takeaways
Health Catalyst reported total revenue of $73.2 million and Adjusted EBITDA of $3.5 million for the second quarter of 2023, exceeding the mid-point of their quarterly guidance. The company is raising its 2023 revenue and Adjusted EBITDA guidance and reiterating its full year 2023 bookings expectations.
Total revenue reached $73.2 million.
Adjusted EBITDA was $3.5 million.
Full year revenue and Adjusted EBITDA guidance were raised.
Full year 2023 bookings expectations were reiterated.
Health Catalyst
Health Catalyst
Health Catalyst Revenue by Segment
Revenue by Segment
Technology Revenue
CapyFin.comProfessional Services Revenue
CapyFin.com Forward Guidance
For the third quarter of 2023, Health Catalyst expects total revenue between $70.2 million and $74.2 million, and Adjusted EBITDA between $0.0 million and $2.5 million. For the full year of 2023, they expect total revenue between $290.5 million and $295.5 million, and Adjusted EBITDA between $10.0 million and $12.0 million.
Positive Outlook
- Total revenue for Q3 2023 is expected to be between $70.2 million and $74.2 million.
- Adjusted EBITDA for Q3 2023 is expected to be between $0.0 million and $2.5 million.
- Total revenue for the full year 2023 is expected to be between $290.5 million and $295.5 million.
- Adjusted EBITDA for the full year 2023 is expected to be between $10.0 million and $12.0 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income